|
|
Fecal impaction is a common concern for 30%–75% of constipated children.2 |  |
Children with impaction are more likely to have fecal incontinence, abdominal pain, and bloating.2 |
 |
Ensuring fecal disimpaction is essential for improved prognosis.3 |  |
PEG demonstrates a significant decrease in impaction cases compared to lactulose (p<0.05).4 |
|
0% children treated with |
15% children treated with |
Abbreviations ▼
PEG: Polyethylene glycol.
References ▼
1. Pashankar DS, Loening-Baucke V, Bishop WP. Safety of polyethylene glycol 3350 for the treatment of chronic constipation in children. Arch Pediatr Adolesc Med. 2003;157(7):661–664. 2. Philichi L. Management of childhood functional constipation. J Pediatr Health Care. 2018;32(1):103–111. 3. Shatnawi MS, Alrwalah MM, Ghanma AM, et al. Lactulose versus polyethylene glycol for disimpaction therapy in constipated children, a randomized controlled study. Sudan J Paediatr. 2019;19(1):31–36. 4. Bastaoros O, Gad MA, Eskander AE, et al. The use of polyethylene glycol as a maintenance treatment of functional constipation in children living in Egypt. Egyptian Pediatr Assoc Gazette. 2023;71:67.
LMRC Code: GGI-CO-A1-AQS-300024228-ELC-I24-1580
For the use of a Registered Medical Practitioner, Hospital or Laboratory only.
Disclaimer:
The images are for illustrative representation only and do not depict actual medical products, procedures, or outcomes. Refer to official medical guidance and product information for accurate details.
All content including: text, images, audio, or other formats were created for medical educational purposes only. Offerings for continuing education are clearly identified and the appropriate target audience is identified. This communication is restricted for the use of HCPs and must not be shared in public domain. The opinions expressed in this video are solely the views of the speaker. The presentation may contain off label usage of drug(s) aimed at educational purpose only. Dr. Reddy’s Laboratories Ltd including but not limited its Affiliates strictly does not recommend any off label usage of its marketing products. Prior to treatment kindly refer to the latest prescribing information approved by the local authorities. No part of this content may be used, reproduced, transmitted or stored in any form without the written permission of Dr. Reddy’s.
